tiprankstipranks
Coya Therapeutics, Inc. (COYA)
NASDAQ:COYA
US Market
Holding COYA?
Track your performance easily

Coya Therapeutics, Inc. (COYA) Income Statement

59 Followers

Coya Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Coya Therapeutics, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Coya Therapeutics, Inc.'s net income was $-4.02M. See Coya Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 9.55M$ 6.00M-$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
$ 9.55M$ 6.00M---
Operating Expense
$ 20.91M$ 13.91M$ 9.81M$ 4.87M$ 694.77K
Operating Income
$ -11.35M$ -7.90M$ -9.81M$ -4.87M$ -694.77K
Net Non Operating Interest Income Expense
---$ 0.00$ -38.98K
Other Income Expense
$ -643.53K$ 96.18K$ -2.96M$ -21.48K$ 550.00
Pretax Income
$ -10.30M$ -7.26M$ -12.24M$ -4.89M$ -733.20K
Tax Provision
$ 723.85K$ 723.85K---
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -10.70M$ -7.99M$ -12.24M$ -4.89M$ -733.20K
Basic EPS
$ -0.66$ -0.79$ -4.73$ -1.26$ -0.19
Diluted EPS
$ -0.66$ -0.79$ -4.73$ -1.26$ -0.19
Basic Average Shares
$ 55.63M$ 10.16M$ 2.59M$ 3.90M$ 3.90M
Diluted Average Shares
$ 55.63M$ 10.16M$ 2.59M$ 3.90M$ 3.90M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 20.91M$ 13.36M$ 9.29M$ 4.87M$ 694.77K
Net Income From Continuing And Discontinued Operation
$ -10.70M$ -7.99M$ -12.24M$ -4.89M$ -733.20K
Normalized Income
$ -10.80M$ -5.74M-$ -4.89M$ -733.20K
Interest Expense
---$ 0.00$ 38.98K
EBIT
$ -9.93M$ -7.36M$ -9.29M$ -4.87M$ -694.22K
EBITDA
$ -9.90M$ -7.33M$ -9.26M$ -4.85M$ -694.22K
Currency in USD

Coya Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis